Breaking News

GenScript Launches Coronavirus Detection Assay

Enables development of reliable molecular diagnostics for faster treatments and vaccines

GenScript, a gene synthesis provider, has launched an assay for detecting the Wuhan novel coronavirus (2019-nCoV). The fast, one-step 2019-nCoV quantitative reverse-transcription polymerase chain reaction (qRT-PCR) detection assay, or reagent, is designed to make it easier and faster to develop reliable molecular diagnostics to identify and treat the virus, and vaccines to ultimately prevent infection.   “Detecting the Wuhan virus in individuals can be difficult due to the long incubation ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters